(385 days)
None
No
The summary describes a mechanical implant (interference screw) and its performance testing, with no mention of AI or ML technologies.
Yes.
The device is used for fixation of grafts during ligament reconstruction, which is a therapeutic intervention aimed at restoring function.
No
The device is an orthopedic implant (interference screw) used for fixation of grafts during ligament reconstruction surgery, not for diagnosing medical conditions.
No
The device description clearly states it is a physical screw made of biocomposite material intended for surgical implantation, which is a hardware device.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information about a person's health. This testing is done outside of the body (in vitro).
- Device Description: The Fixone Biocomposite Interference Screws are described as being used for "fixation of bone or soft tissue grafts during Anterior and/or Posterior Cruciate Ligament (ACL/PCL) reconstruction." This is a surgical implant used within the body.
- Lack of IVD Characteristics: The description does not mention any testing of bodily specimens, analysis of biological markers, or any other activity typically associated with IVDs.
This device is a surgical implant used for orthopedic procedures, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
Fixone Biocomposite Interference Screws are indicated for fixation of bone or soft tissue grafts during Anterior and/or Posterior Cruciate Ligament (ACL/PCL) reconstruction.
Product codes
HWC
Device Description
The Fixone Biocomposite Interference Screws are intended to be used for fixation of bone-tendon-bone or soft tissue grafts during anterior or posterior cruciate ligament reconstruction surgery. This device is could used with instrument that manufactured by Aju Pharm Co.,Ltd. It is consist of 6 models. It provide non-sterile (user must sterilization before use).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Anterior and/or Posterior Cruciate Ligament (ACL/PCL)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Bench test were performed. Bench testing included biocompatibility, mechanical testing, and sterility testing including EO residues. The tests demonstrated that the device performs in a substantially equivalent manner to the predicate device. The following bench testing is performed to demonstrate the functionality is substantially equivalent.
Test items for mechanical testing included: External surface measurement, Tensile strength, Extractable color, Insertion torque, Fixation strength (Push-out test), Extraction test, pH, Potassium permanganate reducing substances, Residue after evaporation, Heavy metals, UV spectrum (250nm~350nm), Property (visual inspection), Performance Testing of Fixone (R) Biocomposite Anchor (Pull-out test), Pull-out test by immersion time of saline solution to evaluate two bioabsorbable suture anchors (Absorption time (soaking time): 4 weeks, 6 weeks, 12 weeks and 26 weeks), and ASTM F1839-08 (Standard specification for RGID Polyurethane Foam for Use as a Standard Material for Testing Orthopaedic Devices and Instruments). All mechanical tests passed.
Biocompatibility tests for the screw included: Cytotoxicity (ISO 10993-5), Acute systemic toxicity test (ISO 10993-11), Pyrogen Test (ISO 10993-11), Intracutaneous (intradermal) reactivity test (ISO 10993-10), Maximization test for delayed hypersensitivity (ISO 10993-10), Bacterial reverse mutation test (ISO 10993-3 OECE 471), Mammalian erythrocyte micronucleus test (ISO 10993-3 OECE 471), Implantation test (ISO 10993-6, Annex D), Bioabsorbable screws test (ASTM F2502), and Subchronic toxicity test (ISO 10993-11). All biocompatibility tests passed.
The performance tests demonstrated that Fixone Biocomposite Interference Screw performs in a substantially equivalent manner to the predicate device.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3040 Smooth or threaded metallic bone fixation fastener.
(a)
Identification. A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
January 5, 2021
Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
AJU Pharm Co., Ltd. % Peter Chung President Plus Global 300 Atwood Street Pittsburgh, Pennsylvania 15213
Re: K193497
Trade/Device Name: Fixone Biocomposite Interference Screw Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth Or Threaded Metallic Bone Fixation Fastener Regulatory Class: Class II Product Code: HWC Dated: December 1, 2020 Received: December 8, 2020
Dear Peter Chung:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
1
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for
Laura C. Rose, Ph.D. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K193497
Device Name Fixone Biocomposite Interference Screw
Indications for Use (Describe)
Fixone Biocomposite Interference Screws are indicated for fixation of bone or soft tissue grafts during Anterior and/or Posterior Cruciate Ligament (ACL/PCL) reconstruction.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
BR
PSC Publishing Services (301) 443-6740
Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2023 See PRA Statement below.
3
510(k) Summary
[as required by 807.92(c)]
1. Applicant
-
- Company : AJU Pharm Co.,Ltd.
- Address : A-207, 697, Pangyo-ro, Seongnam-si, Gyeonggi-do, Korea 2)
- Tel : 82-31-765-4420 3)
- Fax : 82-31-602-7818 4)
-
- Prepared date : Dec. 01, 2019
- ୧) Contact person : Peter Chung, 412-512-8802
-
- Contact person address : 300, Atwood Street, Pittsburgh, PA, 15213, USA
-
- Submission date : Nov. 30, 2020
- ರು) Submission type : Traditional
-
- Prior related submissions : K192484, B-type anchor
2. Device Information
- Trade name : Fixone Biocomposite Interference Screw 1)
-
- Common name : Screw, Fixation, Bone
- Regulation name : Smooth or threaded metallic bone fixation fastener 3)
-
- Product code : HWC
-
- Regulation number : 888.3040
-
- Class of device : Class II
-
- Panel : Orthopedic
3. The legally marketed device to which we are claiming equivalence
K032224, Smith&nephew, Inc. / Smith & Nephew BIORCI HA Screw
4. Device description
The Fixone Biocomposite Interference Screws are intended to be used for fixation of bone-tendon-bone or soft tissue grafts during anterior or posterior cruciate ligament reconstruction surgery.
This device is could used with instrument that manufactured by Aju Pharm Co.,Ltd. It is consist of 6 models. It provide non-sterile (user must sterilization before use).
| Product name | Instrument / 6 model codes including Fixone.I.I-T8090 |
|---|---|
| Intended use | To make a thread and insert a screw in the hole |
| Manufacturer | AJU Pharm Co.,Ltd. / Korea |
| Characteristic | This device is provided as Non-sterile and Reusable device. |
| This device is provided non-sterile. This device is user-sterilized. | |
| Sterilization method | Autoclave / 134°C/ 20 min |
| Material | Grip : Aluminum (Anodized) / Shaft : Stainless Steel (SUS304) |
| Product code | LXH – Orthopedic manual surgical instrument (Class I) |
| Pilot Hole | 4.5 ~ 5.5 mm |
5. Intended Use :
Fixone Biocomposite Interference Screws are indicated for fixation of bone-tendon-bone or soft tissue grafts during Anterior and/or Posterior Cruciate Ligament (ACL/PCL) reconstruction.
6. Performance data:
4
- Bench test were performed. Bench testing included biocompatibility, mechanical testing, and sterility 1) testing including EO residues. The tests demonstrated that the device performs in a substantially equivalent manner to the predicate device. The following bench testing is performed to demonstrate the functionality is substantially equivalent.
| Test item | Requirements | Results |
|---|---|---|
| External surface | ASTM F2502 and USP | |
| Measurement | When tested by vernier calipers, the tolerance should be within ±5% | Pass |
| Tensile strength | The average strength of 10 stands is not less than 100N. | |
| Extractable color | Weigh a quantity of suture, equivalent to not less than 250mg, and place in a | |
| conical flask containing 1.0mL of water for each 10mg of the sample. Close the | ||
| flaskm and allow it to stand at (37±0.5)°C for 24 hours. Coll, decant the water | ||
| from the suture, and compare it with the matching solution : any color present is | ||
| not more intense than of the appropriate matching solution. | MD2014- | |
| 00216 | ||
| Insertion torque | Tested with ASTM F2502-Standard specification and test methods for | |
| bioabsorbable plates and screws for internal fixation implants | Pass | |
| Fixation strength | ||
| (Push-out test) | Tested with ASTM F2502-Standard specification and test methods for | |
| bioabsorbable plates and screws for internal fixation implants | ||
| Tested subject and predicate device under same condition for the comparison | AJU- | |
| M2020100 | ||
| 6-01 | ||
| Extraction test | ||
| pH | The difference should be 1.5 and less. | |
| Potassium permanganate | ||
| reducing substances | The difference of the consumption of potassium permanganate | |
| should be 2.0 mL and less. | ||
| Residue after evaporation | Record the weight of the residue should be 1.0mg and less. | Pass |
| Heavy metals | Any brown color produced within 10 minutes in the tube containing | |
| the extract of the prepared sample does not exceed that in the tube | ||
| containing the standard lead solution | MD2014- | |
| 00132 | ||
| UV spectrum(250nm~350nm) | Maximum absorbance between 250 to 350 nm should be 0.1 and | |
| less. | ||
| Property | When observing it with the naked eye, test solution should be clear | |
| and have no forign particles. | ||
| Performance Testing of Fixone ® Biocomposite Anchor (Pull-out test) | ||
| Pull-out test by immersion time of saline solution to evaluate two bioabsorbable suture anchors. | ||
| [Absorption time (soaking time) : 4 weeks, 6 weeks, 12 weeks and 26 weeks | Ajum2017 | |
| 0428-01 | ||
| ASTM F1839-08, Standard specification for RGID Polyurethane Foam for Use as a Standard Material | ||
| for Testing Orthopaedic Devices and Instruments |
2) Biocompatibility
Screw
| # | Test item | Test method / Test criteria | Test | Rep No. |
|---|---|---|---|---|
| --- | ----------- | ----------------------------- | ------ | --------- |
5
| Result | ||||
|---|---|---|---|---|
| 1 | Cytotoxicity | ISO 10993-5 Biological evaluation of medical devices - Part5: | ||
| Tests for in vitro cytotoxicity | Pass | MD2014-00216 | ||
| 2 | Acute systemic toxicity | |||
| test | ISO 10993-11 Biological evaluation of medical devices - | |||
| Part 11: Tests for systemic toxicity | Pass | MD2014-00132 | ||
| 3 | Pyrogen Test | ISO 10993-11 Test for systemic toxicity, pyrogen test | Pass | MD2014-00132 |
| 4 | Intracutaneous(intrade | |||
| rmal) reactivity test | ISO 10993-10 Biological evaluation of medical devices - Part 10: | |||
| Tests for irritation and skin sensitization | Pass | MD2014-00132 | ||
| 5 | Maximization test for | |||
| delayed | ||||
| hypersensicivity | ISO 10993-10 Test for irritation and skin sensitization, | |||
| Maximization test for delayed hypersensitivity | Pass | MD2014-00216 | ||
| 6 | Bacterial revers | |||
| mutation test | ISO 10993-3 Genotoxicity test OECE 471, Bacterial reverse | |||
| mutation test | Pass | MD2014-00133 | ||
| 7 | Mammalian | |||
| erythrocyte | ||||
| micronucleus test | ISO 10993-3 Genotoxicity test OECE 471, Bacterial reverse | |||
| mutation test | Pass | MD2014-00133 | ||
| 8 | Implantation test | ISO 10993-6 Tests for local effects after implantation, Annex D | ||
| test methods for implantation in bone | Pass | MD2014-00104 | ||
| 9 | Bioabsorbable screws | |||
| test | ASTM F2502 Standard specification and test methods for | |||
| bioabsorbable plates and screws for internal fixation implants | Pass | MD2014-00104 | ||
| 10 | Subchronic toxicity test | ISO 10993-11 Biological Evaluation of Medical Devices Part 11- | ||
| Test for systemic toxicity | Pass | D00021847001- | ||
| 800565.1 |
The performance tests demonstrated that Fixone Biocomposite Interference Screw performs in a substantially equivalent manner to the predicate device.
7. Predicate device comparison table
The Fixone Biocomposite Interference Screw has the similar device characteristics as the predicated device, the Smith & Nephew BIORCI HA Screw; intended use, material, composition, design and use concept are similar.
The Fixone Biocomposite Interference Screw has been subjected to extensive safety, performance, and product validations prior to release. Safety tests have been performed to ensure the devices comply to applicable industry and US regulations.
An extensive review of pertaining to the safety and biocompatibility of Fixone Biocomposite Interference Screw has been conducted.
9. Conclusion
The device is investigated for function to compare the operation of function between Fixone Biocomposite Interference Screw and predicate devices.
Comparison results demonstrate that the specifications and performance of the device are substantially equivalent to the legally marketed predicate device.
Therefore, it is concluded that Fixone Biocomposite Interference Screw is substantially equivalent to the legally marketed predicate device.